Business · 1 sources covering this

Thermo Fisher eyes 15-20% India customer growth on biopharma research boost

The US-based company said it is eyeing continued double-digit growth in India driven by rising demand from biopharma, semiconductor, and clean energy sectors

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·3h ago
Thermo Fisher eyes 15-20% India customer growth on biopharma research boost
The US-based company said it is eyeing continued double-digit growth in India driven by rising demand from biopharma, semiconductor, and clean energy sectors
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/ec6eece61fa3b1e47555667ab26070b005e1a401"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Thermo Fisher eyes 15-20% India customer growth on biopharma research boost"></iframe>

Thermo Fisher eyes 15-20% India customer growth on biopharma research boost

How 1 sources are covering this

Thermo Fisher eyes 15-20% India customer growth on biopharma research boost

More from Business

India’s QS-ranked institutions nearly 5X since 2015

Trai directs utilities, courier and logistics providers to use 1601 series

RPSG Group’s Purvah Green to acquire 1.4 GWp solar plants from ReNew Solar for ₹4,859 crore

Sold property at low price but seller wins tax case

Reader

Trust & legal

Across the network